BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22345301)

  • 21. miRNA expression profiles associated with diagnosis and prognosis in lung cancer.
    Jiang C; Hu X; Alattar M; Zhao H
    Expert Rev Anticancer Ther; 2014 Apr; 14(4):453-61. PubMed ID: 24506710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNAs in human lung cancer.
    Kang SM; Lee HJ
    Exp Biol Med (Maywood); 2014 Nov; 239(11):1505-13. PubMed ID: 24872439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.
    Babashah S; Soleimani M
    Eur J Cancer; 2011 May; 47(8):1127-37. PubMed ID: 21402473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs in colorectal cancer: small molecules with big functions.
    Xuan Y; Yang H; Zhao L; Lau WB; Lau B; Ren N; Hu Y; Yi T; Zhao X; Zhou S; Wei Y
    Cancer Lett; 2015 May; 360(2):89-105. PubMed ID: 25524553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [MicroRNAs and lung cancer].
    Zamani AG; Zamani A
    Tuberk Toraks; 2013; 61(1):57-62. PubMed ID: 23581269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of microRNAs in colorectal cancer.
    Liu M; Chen H
    J Genet Genomics; 2010 Jun; 37(6):347-58. PubMed ID: 20621017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [MicroRNAs and prostate cancer].
    Yang CH; Zhang CN
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):844-9. PubMed ID: 21171273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of multiple microRNAs for expression profiles of microRNAs in lung cancer cell lines by capillary electrophoresis with dual laser-induced fluorescence.
    Ban E; Chae DK; Song EJ
    J Chromatogr A; 2013 Nov; 1315():195-9. PubMed ID: 24094482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis.
    Catuogno S; Cerchia L; Romano G; Pognonec P; Condorelli G; de Franciscis V
    Oncogene; 2013 Jan; 32(3):341-51. PubMed ID: 22370637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic biomarkers in lung cancer.
    Liloglou T; Bediaga NG; Brown BR; Field JK; Davies MP
    Cancer Lett; 2014 Jan; 342(2):200-12. PubMed ID: 22546286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.
    Keller A; Backes C; Leidinger P; Kefer N; Boisguerin V; Barbacioru C; Vogel B; Matzas M; Huwer H; Katus HA; Stähler C; Meder B; Meese E
    Mol Biosyst; 2011 Dec; 7(12):3187-99. PubMed ID: 22027949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA expression signatures in solid malignancies.
    Galasso M; Sandhu SK; Volinia S
    Cancer J; 2012; 18(3):238-43. PubMed ID: 22647360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRNA detection methods and clinical implications in lung cancer.
    Usó M; Jantus-Lewintre E; Sirera R; Bremnes RM; Camps C
    Future Oncol; 2014 Nov; 10(14):2279-92. PubMed ID: 25471039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.